Abstract:Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases worldwide with an unclear mechanism. Long non-coding RNAs (lncRNAs) have recently emerged as important regulatory molecules. To better understand NAFLD pathogenesis, lncRNA and messenger RNA (mRNA) microarrays were conducted in an NAFLD rodent model. Potential target genes of significantly changed lncRNA were predicted using cis/trans-regulatory algorithms. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were then performed to explore their function. In the current analysis, 89 upregulated and 177 downregulated mRNAs were identified, together with 291 deregulated lncRNAs. Bioinformatic analysis of these RNAs has categorized these RNAs into pathways including arachidonic acid metabolism, circadian rhythm, linoleic acid metabolism, peroxisome proliferator-activated receptor (PPAR) signaling pathway, sphingolipid metabolism, steroid biosynthesis, tryptophan metabolism and tyrosine metabolism were compromised. Quantitative polymerase chain reaction (qPCR) of representative nine mRNAs and eight lncRNAs (named fatty liver-related lncRNA, FLRL) was conducted and this verified previous microarray results. Several lncRNAs, such as FLRL1, FLRL6 and FLRL2 demonstrated to be involved in circadian rhythm targeting period circadian clock 3 (Per3), Per2 and aryl hydrocarbon receptor nuclear translocator-like (Arntl), respectively. While FLRL8, FLRL3 and FLRL7 showed a potential role in PPAR signaling pathway through interaction with fatty acid binding protein 5 (Fabp5), lipoprotein lipase (Lpl) and fatty acid desaturase 2 (Fads2). Functional experiments showed that interfering of lncRNA FLRL2 expression affected the expression of predicted target, circadian rhythm gene Arntl. Moreover, both FLRL2 and Arntl were downregulated in the NAFLD cellular model. The current study identified lncRNA and corresponding mRNA in NAFLD, providing new insight into the pathogenesis of NAFLD. Moreover, we identified a new lncRNA FLRL2, that might participate NAFLD pathogenesis mediated by Arntl.

Non-coding RNAs Derailed: the Many Influences on the Fatty Acid Reprogramming of Cancer.

Noncoding RNAs Link Metabolic Reprogramming to Immune Microenvironment in Cancers

The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming

The role of noncoding RNAs in cancer lipid metabolism

Amino acid metabolism regulated by lncRNAs: the propellant behind cancer metabolic reprogramming

The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma

Non-coding RNAs, metabolic stress and adaptive mechanisms in cancer

LncRNAs‐circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers

Noncoding RNAs in regulation of cancer metabolic reprogramming

Role of LncRNAs in regulating cancer amino acid metabolism

Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells

Long non-coding RNAs regulate fatty acid and cholesterol metabolism

LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer

CircRNAs in Cancer Metabolism: a Review

Emerging roles of long noncoding RNAs in enzymes related intracellular metabolic pathways in cancer biology

LncRNAs Regulate Metabolism in Cancer

Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs

Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma

LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling